MedTrace Logo

A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome

NCT00587860 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2010-03-09

Study results available
· View outcomes & findings →

Summary

This study is being done to see if St. John's wort helps people with irritable bowel syndrome, otherwise known as "IBS". St. John's wort is a herbal supplement derived from the St. John's wort plant. It has been shown to be helpful in several medical conditions such as depression as well as other pain syndromes.

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

St. John's wort

Dosage form: Tablet (450 mg) Dose: 450 mg twice a day, placebo twice a day

DRUG

Placebo

Dosage form: Tablet (450 mg) Dose: 450 mg twice a day, placebo twice a day

Sponsors & Collaborators

Principal Investigators

  • Yuri A. Saito Loftus, M.D. M.P.H. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-01-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00587860 on ClinicalTrials.gov